Data from a late-stage study showed that Bristol Myers Squibb’s Zeposia (ozanimod) was unable to significantly improve clinical remission in adult patients with moderate to severe active Crohn’s disease.
BMS’ Zeposia Fails to Meet Primary Endpoint in Phase III Crohn’s Trial Read More »
Guardion Health Sciences, Inc. announced its financial results for the year ended December 31, 2023.
IASO Bio announced that China National Medical Products Administration has approved the Investigational New Drug application for Equecabtagene Autoleucel, a self-developed fully-human anti-B cell maturation antigen chimeric antigen receptor autologous T-cell injection, for an expanded indication in treating relapsed and/or refractory multiple myeloma patients who have undergone 1-2 lines of prior therapies and are refractory
Adlai Nortye Ltd. announced the appointment of Dr. Archie Tse as Head of Research & Development, reporting to Mr. Carsten Lu, CEO and Chairman of Adlai Nortye, effective March 29th, 2024.
Shanghai Junshi Biosciences Co., Ltd, announced its financial results for the full year of 2023 and provided corporate updates.
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company announced that the first patient in China has been dosed in the Phase 1b clinical study of the combination of InnoCare’s novel SHP2.
Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced its 2023 annual results.
The draft plan builds on its predecessor, which the health IT agency said drove “significant progress” in the use and exchange of electronic health information.
New federal health IT strategy increases focus on public health, AI Read More »
The retail pharmacy chain has closed 140 VillageMD locations to date to cut costs, blowing past its previous goal of 60 closures.
Walgreens posts $6B loss on waning VillageMD value; ups clinic closures Read More »
It’s the “most robust and meaningful” regulation streamlining Medicaid eligibility since the Affordable Care Act was implemented a decade ago, one lawyer said.
CMS streamlines Medicaid, CHIP renewal and enrollment in final rule Read More »
